seen from Canada
seen from Germany
seen from United States
seen from China
seen from United States
seen from United States
seen from Japan
seen from Germany
seen from Australia
seen from Malaysia
seen from Germany
seen from United Kingdom
seen from Türkiye
seen from United States
seen from Germany
seen from T1
seen from Germany
seen from United Kingdom
seen from United Kingdom
seen from Japan
Since 1992, 3,4-DAP, was made by Jacobus Pharmaceuticals, a small New Jersey company, until a different company, Catalyst, recently received the exclusive rights to the drug. Catalyst added a preservative, renamed it Firdapse, and is now charging north of $375,000 a year for the life-changing drug.
This is not a story about innovation. This is a story about exploitation.
(continue reading)
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Tablet Firdapse (Amifampridine), Terapi Baru Sindrom Lambert-Eaton Myasthenic
Tablet Firdapse (Amifampridine), Terapi Baru Sindrom Lambert-Eaton Myasthenic
farmasetika.com – Lambert ‐ Eaton myasthenia (LEM) adalah kelainan autoimun langka yang sering dikaitkan dengan keganasan, biasanya kanker paru-paru sel kecil (Juel, 2015). Studi epidemiologis menunjukkan bahwa sekarang mungkin ada sekitar 800 pasien dengan LEM di AS dan hingga 170 kasus baru setiap tahunnya (Abenroth DC et al., 2017).
Dalam neuron, saluran kalsium tegangan-gated (VGCCs)…
View On WordPress
Catalyst Pharmaceuticals to report Q4 earnings
Catalyst Pharmaceuticals to report Q4 earnings
Shares of the biopharma firm Catalyst Pharmaceuticals (Nasdaq: CPRX) has jumped above 60% this year after it received FDA approval for Firdapse, a drug used for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS). The company is scheduled to report its Q4 earnings results today after the bell.
As the company launched Firdapse across the US in January, investors would be interested in…
View On WordPress
From 0 to $375,000...
Read more...
- ED - "The point is, ladies and gentleman, that greed, for lack of a better word, is good. Greed is right, greed works. Greed clarifies, cuts through, and captures the essence of the evolutionary spirit. Greed, in all of its forms; greed for life, for money, for love, knowledge has marked the upward surge of mankind." - Gordon Gekko
Bernie, I'm with you on this one!
Catalyst acquired the North American license for Firdapse (a free drug) and then announced, in a December 13 phone call with investors, its intention to set the list price at $375,000,
https://www.cnn.com/2019/02/04/health/bernie-sanders-firdapse-catalyst-bn/index.html
time to make some laws and restrict profits pharma can make on drugs (most of which are developed by taxpayer dollars)
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
FDA approves first treatment Firdapse (amifampridine) for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
FDA approves first treatment Firdapse (amifampridine) for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
FDA approves first treatment Firdapse (amifampridine) for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder that affects the connection between nerves and muscles and causes weakness and…
View On WordPress
